Preserving the function of the guardian of the genome, p53: Luteolin inhibits functional inactivation of p53 by somatic mutation and viral oncognes via up regulation of its target gene, 30/January/2015, 18.10

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, Preserving the function of the guardian of the genome, p53:  Luteolin inhibits functional inactivation of p53 by somatic mutation and viral oncognes via up regulation of its target gene, 30/January/2015, 18.10, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that Luteolin, by increasing the expression of its target gene, it may inhibit the functional inactivation of p53 by somatic mutation and viral oncognes. Thereby, it may safeguard the function of the guardian of the genome, p53. Thus, pharmacological formulations encompassing “Luteolin or its analogues”  may be used to inhibit the development of human tumors. 

Amount: $ 500*

Undisclosed information: How Luteolin preserves the function of the guardian of the genome, p53

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation